Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICOS

Executive Summary

Seattle-based biotech startup is currently in the process of a private placement offering which is expected to be completed in June. Venture capitalists Issac and David Blech are the principal financiers and Paine Webber is handling the placement. Founded in the fall of 1989, the company is headed by three major biotech execs: Chairman of the Board George Rathmann, PhD, (currently chairman of Amgen); President and CEO Robert Nowinski, PhD, (former VP Bristol Myers and founder of Genetics Systems); and Science Director Christopher Henney, PhD, (cofounder of Immunex). The company's focus will be the development of biotech and pharmaceutical therapeutics for the treatment of inflammatory diseases.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017504

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel